Edgar Khayat

𝗦𝗽𝗮𝗿𝘀𝗵𝗠𝗶𝗻𝗱 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻𝘀' 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗦𝘁𝘂𝗱𝘆 𝗦𝗲𝗹𝗲𝗰𝘁𝗲𝗱 𝗳𝗼𝗿 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗮𝘁 𝘁𝗵𝗲 𝟭𝟲𝘁𝗵 𝗪𝗼𝗿𝗹𝗱 𝗦𝘁𝗿𝗼𝗸𝗲 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 We are pleased to announce that our clinical study has been accepted for presentation at the 𝟭𝟲𝘁𝗵 𝗪𝗼𝗿𝗹𝗱 𝗦𝘁𝗿𝗼𝗸𝗲 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 (𝗪𝗦𝗖 𝟮𝟬𝟮𝟰), scheduled to take place in Abu Dhabi, UAE, from October 23-26, 2024. The Congress brings together the world’s 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝘀𝘁𝗿𝗼𝗸𝗲 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀, 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀, 𝗮𝗻𝗱 𝗽𝗼𝗹𝗶𝗰𝘆𝗺𝗮𝗸𝗲𝗿𝘀 to discuss the latest advancements in stroke care, making this an incredible opportunity for our team to 𝘀𝗵𝗼𝘄𝗰𝗮𝘀𝗲 𝗼𝘂𝗿 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗼𝗻 𝗮 𝗴𝗹𝗼𝗯𝗮𝗹 𝘀𝘁𝗮𝗴𝗲. The selection of our study for presentation at this esteemed event represents a 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝗺𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗳𝗼𝗿 𝗦𝗽𝗮𝗿𝘀𝗵𝗠𝗶𝗻𝗱 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻𝘀. It underscores the relevance and potential impact of our research in the field of stroke rehabilitation and care. We are honored to have the opportunity to contribute to the global dialogue on improving stroke outcomes. This achievement is the result of our team's collective effort and dedication. We would 𝗹𝗶𝗸𝗲 𝘁𝗼 𝗮𝗰𝗸𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲 𝘁𝗵𝗲 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝗰𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗶𝗼𝗻 of Zubina Khan, whose diligence and expertise were crucial in the 𝗽𝗿𝗲𝗽𝗮𝗿𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝗼𝗳 𝗼𝘂𝗿 𝘀𝘁𝘂𝗱𝘆. 𝗢𝘂𝗿 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝘁𝘂𝗱𝘆 𝗳𝗼𝗰𝘂𝘀𝗲𝘀 𝗼𝗻: 1) 𝟭𝗵𝗿 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲𝘀 𝘂𝘀𝗮𝗴𝗲 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗱𝗶𝘇𝘇𝗶𝗻𝗲𝘀𝘀 𝗼𝗿 𝗱𝗶𝘀𝗰𝗼𝗺𝗳𝗼𝗿𝘁- proving our teams capabilities to develop VR content with deep design understanding  2) 𝗜𝗻𝗱𝗲𝗽𝗲𝗻𝗱𝗲𝗻𝗰𝗲 𝗼𝗳 𝘂𝘀𝗮𝗴𝗲, which can be pivotal for centers to manage their patient flow 3) 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗲𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 for 1hr and interest for repeat usage. Which shows the fundamental understanding of human behavior We look forward to sharing our findings with the international stroke community and engaging in meaningful discussions that may shape the future of stroke care. HARI KRISHNAN M | Hriushikesh Wadekar | Abhijith Unni | #WorldStrokeCongress2024 #WSC2024 #StrokeResearch #StrokeRehabilitation #SparshMindInnovations #HealthcareInnovation #MedicalResearch #NeurologyAdvances #StrokeCare

42

2 Comments

🩺🌟Join experts Dr Owais Dar and Mr Espeed Khoshbin as they explore the timing of heart transplantation and LVAD implantation, sharing key insights into decision-making for improved patient outcomes. Watch the full webinar on demand 👉 https://ow.ly/QCLm50Uk7ok #CardioEd #HeartTransplant #LVAD #HeartFailure

1

We asked our experts Annabel de Maria Bosch and Giulia Pierini to answer the most frequently asked questions about patient-centric product strategy, and here's what they had to say: https://lnkd.in/ePx43vKB 💡 Don't miss the chance to ask Giulia your #patientengagement questions in person next week at #PatientsAsPartners Europe. #PatientsEU2024

45

The Case Mix Index (CMI) and Diagnosis-Related Group (DRG) implementation in Saudi Arabia have been pivotal in revolutionizing healthcare management and resource allocation. CMI is a metric used to assess the complexity of patients treated in a healthcare facility, reflecting the average diagnosis and treatment intensity. Meanwhile, DRGs categorize patients with similar diagnoses and treatment procedures into homogeneous groups for billing purposes. In Saudi Arabia, the adoption of CMI and DRGs has aimed to enhance healthcare efficiency, quality, and financial sustainability. By utilizing CMI, hospitals can better understand patient acuity levels, allowing for more accurate resource allocation and staffing decisions. DRGs further streamline this process by facilitating standardized billing and reimbursement based on patient groups. This implementation has facilitated transparency in healthcare financing, aiding in cost containment and budget planning. Moreover, it has incentivized hospitals to optimize care delivery, leading to improved patient outcomes and satisfaction. However, challenges such as data quality, coding accuracy, and adaptation to the unique healthcare landscape of Saudi Arabia have required continuous refinement and investment. Overall, the integration of CMI and DRGs in Saudi Arabia reflects a commitment to modernizing healthcare management practices, ultimately striving for more effective and equitable healthcare delivery. organized by Council Of Health Insurance Racha M Naim, CHIP, RCMS and other team members for an amazing presentation and looking forward for many such events. #vision2030 #JHAH #CHI #Medicalinsurance #DRG #RCM #HIMS #casemixindex

11

1 Comment

Our full article on the budget impact of Infliximab SC versus all other IV versions for the Saudi Payer perspective has just been released. Thanks to all our contributors from different health and academic institutions in Saudi Arabia for their support https://lnkd.in/dxiJbYV2

18

3 Comments

🔎 Why Endoscopy Matters: Reducing NHS Waiting Lists for Better Health Endoscopy is a critical tool for diagnosing conditions like bowel disease and cancer early—when treatment is most effective. But with NHS waiting lists still at a high, many patients are facing delays, which can have serious impacts on health outcomes. At medcareworld, we are committed to supporting the NHS in tackling these backlogs. Our innovative health solutions streamline endoscopy services, helping to reduce waiting times and ensure patients get the care they need sooner. It is important to prioritise early diagnosis and efficient care. So, let us keep the conversation going on how we can improve access and reduce those waiting lists—because health cannot wait. For more information on the services we provide or to speak to us about the ways in which our solutions can help your NHS Trust, please contact Greg Clarke at [email protected]. #Endoscopy #Gastroenterology #HealthcareSolutions #NHS #ElectiveCare #EarlyDiagnosis #HealthCareTransformation #PatientCare #ClinicalInsourcing

6

Curious about what’s new at Medlab Middle East Congress 2025? Let’s explore the future of medical laboratories and healthcare together! For conference inquiries, check the link below https://bit.ly/4fEsFoL #myMedlab #medlabmiddleeast2025

16

💎MedTech Wins! New Markets, New Milestones Here are a sample of just a few recent registrations in the Middle East. What market is your MedTech product aiming to enter next? Let’s discuss how we can help you get there! Try out our MARI score to see your readiness level for entry into new markets. Discover how we simplify complex global registrations. Click here to learn more ➡️https://hubs.ly/Q02-rn6C0 #MedTechInnovation #RegulatoryStrategy #MedicalDevices #GlobalMarkets #ArazyGroup

2

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029 Download PDF Brochure @ https://lnkd.in/dYssGN5u The size of global 𝐡𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $92.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 6.5% from 2024 to 2029 Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the #POCdiagnostics market. This is primarily due to the high and growing prevalence of #diabetes, #chronickidneydiseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for #dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Kidney Institute of the Desert      American Hospital Tanta      American Dialysis Centers      Wellspring Health and Rehabilitation of Cascadia      AzFar Med    Adventist Hospital - Santiago City, Inc.      Elik Dialysis      The Vascular Group of Naples - (Florida)      The Medical Pavilion Bahamas     FMC-NA Concentrates Saint Francis Doctors' Hospital and Medical Center       Molded Products, Inc      Sandor Dialysis Services Bangladesh      Alaska Dialysis      Ratchaphruek Hospital      Devaki Speciality Hospital      Puremeditech      San Francisco Vein & Vascular Institute      Nephrology Associates of Northern Virginia, Inc.      Branson Nephrology & Dialysis     Olympic Peninsula Kidney Center      KCPmed group   Clinical Renal Associates      Einat Medical Agencies Ltd.      NEPHROLOGY & HYPERTENSION, PC      Guangde People's Hospital  High Desert Nephrology Associates      Centro Nefrológico    Adventist Medical Center - Valencia City  Salamat Andishan Public Hospital Establishment - Ghazaouet     BP Renalcare    Instituto del Riñon      Home Dialysis      The Grove At the Lake      Saint Gregory the Illuminator Medical Center      United Doctors Medical      Avista Nursing and Rehab      PT Indo Medika Utama     

1

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029 Download PDF Brochure @ https://lnkd.in/dYssGN5u The size of global 𝐡𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $92.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 6.5% from 2024 to 2029 Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the #POCdiagnostics market. This is primarily due to the high and growing prevalence of #diabetes, #chronickidneydiseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for #dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Q Medical Industries      Hanover & District Hospital      Physician Software Systems      SCW Medicath     Farmasol Tıbbi Ürünler San. ve Tic. A.Ş.      Renal Associates of Baton Rouge, LLC.       Northern California Nursing Academy      PT. Arianda Putra Pratama      Freedom At Home Dialysis      CEREHA S.A.      Inspira Health Group      PT. Oriontama Jaya      Vascular Surgery Associates      RenalWorks      tek-imaş Medıkal      Tianck Medical Co.,Ltd      PT Sing Aji Sentosa      SMT GROUP      Alzahra-Hospital      Austin Kidney Associates      Mobil Dialysis     Midwest Nephrology Associates      Meditechsys      Adventist Hospital Cebu      Sanxin Medtec      Hasheminejad Kidney Center      Physicians Choice Dialysis      Diaverum Hungary  North Mountain Medical and Rehabilitation Center     Nelson Environmental Technologies, Inc.      San Antonio Kidney      Haddon Renal Medical Specialsts      Dialyspa      Ayamed      Eastbrook Healthcare Center      The Medical City South Luzon         Biocompany Comércio e Serviços Ltda.   

1

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029 Download PDF Brochure @ https://lnkd.in/dYssGN5u The size of global 𝐡𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $92.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 6.5% from 2024 to 2029 Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the #POCdiagnostics market. This is primarily due to the high and growing prevalence of #diabetes, #chronickidneydiseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for #dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: SWS Hemodialysis Care Co.,Ltd        Hemodialysis Inc     Hemodialysis Inc.      HEMODIALYSIS CLINIC      HEMODIALYSIS SERVICES, INC.      Outset Medical, Inc.      Nipro Medical Corporation      Dialysis Clinic, Inc.      Satellite Healthcare / WellBound      Somatus      Diality      Mozarc Medical      American Nephrology Nurses Association (ANNA)      Long Island Community Hospital      Nephrology Nursing Certification Commission (NNCC)      Humacyte      Dialysis Care Center      Transonic Systems Inc.      Fresenius Medical Care      SBH Health System      Almoosa Health Group      Alio      Cara Therapeutics      Artio Medical, Inc.      NephroPlus      Dialyze Direct      Nipro Medical India      Ghalioungui Trading      Quanta Dialysis Technologies      Bellco is now part of Medtronic      Dialysis Education Services      Global Medical City جلوبال ميديكال سيتي        RenViva      HHD Home Healthcare LLC      Gada Spa     AlRazi Pharma Industries      Cormedix Inc.      PT.Enseval Putera Megatrading Tbk      Lepu Medical Technology (Beijing) Co., Ltd. 

3

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029 Download PDF Brochure @ https://lnkd.in/dYssGN5u The size of global 𝐡𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $92.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 6.5% from 2024 to 2029 Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the #POCdiagnostics market. This is primarily due to the high and growing prevalence of #diabetes, #chronickidneydiseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for #dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: DWA GmbH & Co. KG      ForteCare Indústria de Produtos Médicos        ADHE-ELS SA      Central Florida Kidney Centers, Inc.      AVERICUM      Apollo Dialysis Clinics      Orchard Hill Rehabilitation & Healthcare Center      AMSA Healthcare      Baihe Medical Technology      Pure Life Renal      Providence Hospital Inc      NEPHROLOGY AND HYPERTENSION ASSOCIATES      Abubakar Tafawa Balewa University Teaching Hospital, Bauchi      Laurel Brook Rehabilitation & Healthcare Center      Nodford International Co.,Ltd      Sacred Heart Hospital of Malolos Inc.      Dr.Bassam Medical Center      Orlando Clinical Research Center      PT Masa Lestari Husada - PT Masa Cipta Husada       Redsense Medical      Light Line Medical, Inc.      AOSS Medical Supply      Kawasumi Laboratories America      Hemotek Renal Center, Inc.      Mobile Vet      IDR - Instituto de Doenças Renais S.A.      National Medical College & Teaching Hospital      Bioteque Corporation      Roosevelt Rehabilitation & Healthcare Center        Medicare Jordan      INTERSKALA MEDIKA INDONESIA      Vital Healthcare Sdn Bhd      Divine Heart & Multispecialty Hospital      Bridgewater Center For Rehabilitation and Nursing      Dialife SA      Rumah Sakit Umum Bhakti Asih      The Hospital at Maayo      DaVita Malaysia  

1

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029 Download PDF Brochure @ https://lnkd.in/dYssGN5u The size of global 𝐡𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $92.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 6.5% from 2024 to 2029 Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the #POCdiagnostics market. This is primarily due to the high and growing prevalence of #diabetes, #chronickidneydiseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for #dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Estor      Healthcare Alliance KSA      NephroCan      Puget Sound Kidney Centers      Lincolnwood Rehabilitation & Healthcare Center        Kanishk Surgical & Super Specialty Hospital      Western Nephrology    Renal Research Institute (RRI) )       Erbil International Hospital      Sunshine Factory Co., Ltd. (Mianzhu Yaolong)      Dirinco      Guangzhou MeCan Medical Limited      Amsa Renal Care      Renacon Pharma Ltd.      Pathfinder Medical      TEMAK S.A      Haidylena for Medical Industries      Avenu Medical      Goodwill Staffing & Recruitment      SIDANAH International Co. Ltd        Orange Technical College Winter Park & Avalon      Tuoren Medical         National Renal Care, LLC      Los Alamitos Hemodialysis Ctr      Acail Saúde     BIMC Hospital Nusa Dua      Merciful Hands Health Care       Alfa Laboratories S.A.L      H&S Technical Services, A Nipro Company     WEGO Blood Purification Business Group     Dreavia      Renalyx Health Systems Pvt. Ltd 

2

Hemodialysis and Peritoneal Dialysis Market wort $126.2 billion by 2029 Download PDF Brochure @ https://lnkd.in/dYssGN5u The size of global 𝐡𝐞𝐦𝐨𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐩𝐞𝐫𝐢𝐭𝐨𝐧𝐞𝐚𝐥 𝐝𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐭𝐞𝐫𝐦𝐬 𝐨𝐟 𝐫𝐞𝐯𝐞𝐧𝐮𝐞 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 $92.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐨𝐢𝐬𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $126.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 6.5% from 2024 to 2029 Emerging markets such as #China, #India, #Brazil, are expected to offer significant growth opportunities for players operating in the #POCdiagnostics market. This is primarily due to the high and growing prevalence of #diabetes, #chronickidneydiseases, in these countries. As economic growth in China and India continues to expand, there is rise in healthcare spending across these countries, which leads to improved affordability of hemodialysis and peritoneal dialysis treatment. According to the article published by 𝐁𝐌𝐂 𝐍𝐞𝐩𝐡𝐫𝐨𝐥𝐨𝐠𝐲 in China, the prevalence of ESRD is projected to reach 1,505 patients per million population by 2025. To meet the increasing demand for #dialysis in the emerging markets, players focus on acquiring or entering into agreements and partnerships with healthcare providers. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Rockwell Medical, Inc.      Guangdong Biolight Meditech Co., Ltd.      D.med Healthcare Group     DSI Renal      Tuoren Medical Device India Pvt. Ltd.      Nephro Arabia      Apex Kidney Care Pvt Ltd      AWAK Technologies      Cayman Islands Health Services Authority        Well Lead Medical Co., Ltd.     ICD Group.     Nextkidney  Fresenius Medical Care Portugal     Cornwall Community Hospital      Rivamed(Beijing) S&T Co; Ltd.      Trivita Healthcare L.L.C.      Rogosin Institute      Landwind Medical      Greensboro Radiology      Laminate Medical Technologies Ltd.      BAIN MEDICAL EQUIPMENT (GUANGZHOU) CO., LTD    WMG Biomedical Engineering PLC      PHYSIDIA Alice Hyde Medical Center      Pacific International Hospital      Raleigh General Hospital      InterHealth Canada - Turks and Caicos Islands Hospital    Médica Santa Carmen Miamed Pharmaceutical Industries      Alucent Biomedical, Inc.      Amicis Research Center    LifeCare Foundation Medical Staffing     Delta Instrument Technology PLC.     KidneySolutions

1

IN PRESS: ADC implementation in surgical settings was found to decrease medication errors, reduce drug diversion/, improve inventory management, and increase workforce satisfaction. #Pharmacists #ForPharmacy https://lnkd.in/eJMNKfD9

3

Market Access Today is thrilled to announce its role as the official partner of the upcoming MENAHTA Forum 2024, a leading conference dedicated to Health Technology Assessment (HTA) excellence in the Middle East and North Africa (MENA) region. Scheduled for June 5th, 2024, at the prestigious Le Méridien Dubai Hotel + Conference Centre, this event promises to be a pivotal gathering for regulatory, market access, pricing, and commercial experts in the life sciences sector. The MENAHTA Forum 2024 is designed to educate and empower pharmaceutical industry decision-makers and distributors on the successful implementation of HTA in the MENA region. Attendees will gain critical insights into how HTA is shaping the future of healthcare and how it can drive commercial success during this transformative period. Key agenda highlights include discussions on the value approaches for innovative pharmaceutical products, HTA advancements and regional insights from Jordan, cost-effectiveness thresholds in the UAE, the importance of evidence generation for HTAs, and strategies for implementing value-based technology assessments. As the official partner, Market Access Today is proud to support this essential forum, which aligns with our commitment to fostering innovation and excellence in healthcare. We invite pharmaceutical professionals, distributors, and wholesalers to join us for this enlightening event to enhance their knowledge and strategies for market access in the MENA region. For more information: https://lnkd.in/drwTFYD5 Special Offer: Attendees can enjoy a 15% discount on registration by using the code "ZAG15". Register now to secure your spot at the MENAHTA Forum 2024, and prepare to engage in insightful discussions that will undoubtedly influence the future of healthcare in our region. We look forward to welcoming you and contributing to a day of significant learning and networking opportunities. #menahta #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #pharmacoeconomics #health #pharmaceuticals #medicaldevices #HTA #MENA

21

1 Comment

Andre Andonian, Flagship Chair of Asia Pacific and Strategic Advisor, spoke at the Bloomberg #QatarEconomicForum on a panel on the digital transformation of healthcare moderated by Bloomberg Senior Editor Bobby Ghosh. Watch the full panel during which André highlights how Flagship is pioneering AI-enabled panels that transform drug discovery, and how Flagship-founded Generate:Biomedicines is turning biology into a truly engineerable discipline. https://bit.ly/4apiykn

18

1 Comment

✴️ New results have been published estimating the testing requirement to double the diagnostic rates of ≥ F2 MASH over a 5-year period in France, Germany, UK and USA! ➡️ By doubling this rate in all four countries, the number of patients diagnosed will increase from 2.6m to 6.1m between 2022 and 2027. To achieve this, several approaches need to be set up: >> Early intervention is both possible and desirable, to improve outcomes and reduce costs >> More screening calls are needed to strengthen healthcare infrastructure >> Doubling the diagnoses and multiplying the collaborative efforts >> A person-centered approach Echosens supports and advances the liver health management and diagnosis with its gold-standard non-invasive solutions in order to improve the management of silent and under-diagnosed chronic liver diseases. Check the poster now 👉 https://lnkd.in/gPAXqiWe Jeffrey V. Lazarus #FibroScan #LiverHealthMatters #EASL2024

83

1 Comment